AbCellera Biologics (ABCL) Other Non Operating Income (2020 - 2026)
AbCellera Biologics' (ABCL) quarterly Other Non Operating Income came in at $4.3 million in Q1 2026, up 4.48% YoY from $4.2 million in Q1 2025, and up 132.66% on a QoQ basis from -$13.3 million in Q4 2025.
AbCellera Biologics (ABCL) Other Non Operating Income (2020 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 7 years of Other Non Operating Income data on file, last reported at $4.3 million in Q1 2026.
- Quarterly Other Non Operating Income rose 4.48% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (up 89.47% YoY) and the FY2025 annual result came in at -$2.7 million, down 119.9% from the prior year.
- Other Non Operating Income grew to $4.3 million in Q1 2026, from -$13.3 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $10.8 million in Q4 2022 to a low of -$34.9 million in Q4 2024.
- A 5-year average of $403176.5 and a median of $3.4 million in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income jumped 418.0% — and 2024, when it plunged 1135.07%.
- Tracing ABCL's Other Non Operating Income over 5 years: stood at $10.8 million in 2022, then tumbled by 68.8% to $3.4 million in 2023, then sank by 1135.07% to -$34.9 million in 2024, then jumped by 61.98% to -$13.3 million in 2025, then jumped by 132.66% to $4.3 million in 2026.
- The last three Other Non Operating Income figures came in at $4.3 million (Q1 2026), -$13.3 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.85 Mn |
| Mar 31, 2026 | 4.34 Mn |
| Dec 31, 2025 | -13.29 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 3.69 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Dec 31, 2024 | -34.94 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 4.58 Mn |
| Mar 31, 2023 | 3.59 Mn |
| Dec 31, 2022 | 10.82 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | -1.44 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | -5.49 Mn |
| Sep 30, 2021 | 4.38 Mn |